Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Medanta- The Medicity

1 abstract

Abstract
Real-world, single-center experience on the outcomes of neoadjuvant chemotherapy and trastuzumab alone or in combination with pertuzumab in human epidermal growth factor receptor-2 breast cancer patients.
Org: Medanta Medicity, Medanta - The Medicity, Medanta- The Medicity, Medanta-The Medicity, Medanta The Medicity,